Outlook (2021-2030) on Global Lupus Nephritis Market: Industry Analysis
Press
Release - 16 April 2018
Global
Research and Development News
--
.
.
Report
Description-
'
'
Lupus nephritis is inflammation of the
kidney that is caused by systemic lupus erythematous (SLE). Also
called lupus, SLE is an autoimmune disease where the immune system
turns against the body, affecting vital organs. While the primary
cause of the disease is unknown, it is expected that factors such as
viruses, infections, pollutants, and toxic chemicals, along with
family history plays a role in causing the disease. The disease is
more common in women compared to men. Kidney damage from lupus
erythematosus can vary from mild to severe. In lupus nephritis,
glomeruli or the filtering units are damaged. As a result, waste from
the blood does not get filtered. Lupus nephritis happens when lupus
involves the kidneys. When the kidneys are inflamed, they cannot
function normally and can leak protein. If not controlled, lupus
nephritis can lead to kidney failure.
'
'
The treatment for Lupus Nephritis is based
upon on its type, which is determined by the biopsy. Since, symptoms
and severity vary from person to person, treatments are individually
tailored to meet a person's particular circumstances.
The global Lupus Nephritis market is set to
experience favourable growth driven by factors such as increasing
African-American population, rising health care expenditure and
accelerating economic growth. The major trends observed in the market
are new drugs under pipeline for Lupus Nephritis, increasing research
grants with rising public awareness about the disease. However, the
growth of this budding market will be hindered by stringent
regulations, associated risk and high cost.
The report “Global Lupus Nephritis Market:
Industry Analysis & Outlook (2021-2030)” analyses the
development of this market, with focus on the U.S, Europe and Japan
markets. The major trends, growth drivers as well as issues being
faced by the market are discussed in detail in this report. The five
major players: Aurinia Pharmaceuticals Inc., Roche Holding AG,
Bristol-Myers Squibb, GlaxoSmithKline Plc. and AstraZeneca are being
profiled along with their key financials and strategies for growth.
The report contains a comprehensive analysis of the global Lupus
Nephritis market along with the study of the regional markets.
– More
Clear Details get Table of Contents
https://www.researchmoz.us/global-lupus-nephritis-market-industry-analysis-outlook-20212030-report.html/toc
'
'
1. Overview
1.1 Introduction
1.2 Symptoms
1.3 Classification
1.4 Treatment
2. Global Market Analysis
2.1 Global Lupus Nephritis Patient Population Forecast
2.2 Global Lupus Nephritis Market Forecast by Value
2.3 Global Lupus Nephritis Market by Region
3. Regional Market Analysis
3.1 The U.S.
3.1.1 The U.S. SLE Patient Population Forecast
3.1.2 The U.S. Lupus Nephritis Patient Population Forecast
3.1.3 The U.S. Lupus Nephritis Market Forecast by Value
3.2 Europe
3.2.1 Europe Lupus Nephritis Patient Population Forecast
3.2.2 Europe Lupus Nephritis Market Forecast by Value
3.3 Japan
3.3.1 Japan Lupus Nephritis Patient Population Forecast
3.3.2 Japan Lupus Nephritis Market Forecast by Value
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rise in African-American Population
4.1.2 Accelerating Economic Growth
4.1.3 Rising Health Care Expenditure
4.1.4 Increasing Prevalence of Lupus Nephritis
4.2 Key Trends & Development
4.2.1 Drugs under Pipeline for Lupus Nephritis
4.2.2 Increasing Research Grants
4.2.3 Rising Public Awareness
4.3 Challenges
4.3.1 Stringent Regulations
4.3.2 Associated Risk
4.3.3 High Costs
5. Competition
5.1 Global Market
5.1.1 Global Lupus Nephritis Market- Revenue Comparison of Key Companies
5.1.2 Global Lupus Nephritis Market- Market Cap Comparison of Key Companies
6. Company Profiles
6.1 Aurinia Pharmaceuticals Inc.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Roche Holding AG
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Bristol-Myers Squibb
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 GlaxoSmithKline Plc.
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
1.1 Introduction
1.2 Symptoms
1.3 Classification
1.4 Treatment
2. Global Market Analysis
2.1 Global Lupus Nephritis Patient Population Forecast
2.2 Global Lupus Nephritis Market Forecast by Value
2.3 Global Lupus Nephritis Market by Region
3. Regional Market Analysis
3.1 The U.S.
3.1.1 The U.S. SLE Patient Population Forecast
3.1.2 The U.S. Lupus Nephritis Patient Population Forecast
3.1.3 The U.S. Lupus Nephritis Market Forecast by Value
3.2 Europe
3.2.1 Europe Lupus Nephritis Patient Population Forecast
3.2.2 Europe Lupus Nephritis Market Forecast by Value
3.3 Japan
3.3.1 Japan Lupus Nephritis Patient Population Forecast
3.3.2 Japan Lupus Nephritis Market Forecast by Value
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rise in African-American Population
4.1.2 Accelerating Economic Growth
4.1.3 Rising Health Care Expenditure
4.1.4 Increasing Prevalence of Lupus Nephritis
4.2 Key Trends & Development
4.2.1 Drugs under Pipeline for Lupus Nephritis
4.2.2 Increasing Research Grants
4.2.3 Rising Public Awareness
4.3 Challenges
4.3.1 Stringent Regulations
4.3.2 Associated Risk
4.3.3 High Costs
5. Competition
5.1 Global Market
5.1.1 Global Lupus Nephritis Market- Revenue Comparison of Key Companies
5.1.2 Global Lupus Nephritis Market- Market Cap Comparison of Key Companies
6. Company Profiles
6.1 Aurinia Pharmaceuticals Inc.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Roche Holding AG
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Bristol-Myers Squibb
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 GlaxoSmithKline Plc.
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
Comments
Post a Comment